Home Biosimilar Antibodies Others Others antibody Eculizumab (Anti-Complement C5) For research use only.
Not for use in humans.

Eculizumab (Anti-Complement C5)

Synonyms: Anti-Human C5, Humanized Antibody

Eculizumab (Anti-Complement C5) is a long-acting humanized monoclonal antibody targeting against complement C5. Eculizumab inhibits the cleavage of C5 into C5a and C5b and hence inhibits deployment of the terminal complement system including the formation of membrane attack complex (MAC). Eculizumab has the potential for haemolysis research. MW: 145.5 KD.

Eculizumab (Anti-Complement C5)

Purity & Quality Control

Batch: A253801 Purity: 99% Protein concentration: 11.6mg/ml Endotoxin Level: ＜1EU/mg
99

Biological Activity

Description Eculizumab (Anti-Complement C5) is a long-acting humanized monoclonal antibody targeting against complement C5. Eculizumab inhibits the cleavage of C5 into C5a and C5b and hence inhibits deployment of the terminal complement system including the formation of membrane attack complex (MAC). Eculizumab has the potential for haemolysis research. MW: 145.5 KD.

Product Details

CAS No. 219685-50-4
Molecular Weight 145.5 kDa
Isotype Human IgG1
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Eculizumab (Anti-Complement C5) | Eculizumab (Anti-Complement C5) supplier | purchase Eculizumab (Anti-Complement C5) | Eculizumab (Anti-Complement C5) cost | Eculizumab (Anti-Complement C5) manufacturer | order Eculizumab (Anti-Complement C5) | Eculizumab (Anti-Complement C5) distributor